Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BI-2536 | PE/CA-PJ15 | 0.0017 | 1 | | 1123 | 1056 | 25 | 6 | 36 | 94.03 | 2.76 | 3.21 | 6 | G09 | |
| BI-2536 | PE/CA-PJ15 | 0.0017 | 2 | | 2022 | 1902 | 45 | 0 | 75 | 94.07 | 2.23 | 3.71 | 6 | G09 | |
| BI-2536 | PE/CA-PJ15 | 0.0017 | 3 | | 3334 | 3149 | 54 | 0 | 131 | 94.45 | 1.62 | 3.93 | 6 | G09 | |
| MLN8054 | PE/CA-PJ15 | 0.0017 | 1 | | 1140 | 1065 | 27 | 6 | 42 | 93.42 | 2.89 | 3.68 | 6 | G10 | |
| MLN8054 | PE/CA-PJ15 | 0.0017 | 2 | | 2244 | 2088 | 82 | 0 | 74 | 93.05 | 3.65 | 3.30 | 6 | G10 | |
| MLN8054 | PE/CA-PJ15 | 0.0017 | 3 | | 3214 | 3017 | 85 | 0 | 112 | 93.87 | 2.64 | 3.48 | 6 | G10 | |
| PE/CA-PJ15 | 1 | | 1074 | 1023 | 17 | 4 | 30 | 95.25 | 1.96 | 2.79 | 6 | G11 | N | ||
| PE/CA-PJ15 | 2 | | 2057 | 1966 | 34 | 0 | 57 | 95.58 | 1.65 | 2.77 | 6 | G11 | N | ||
| PE/CA-PJ15 | 3 | | 3019 | 2892 | 37 | 0 | 90 | 95.79 | 1.23 | 2.98 | 6 | G11 | N | ||
| MLN8054 | PE/CA-PJ15 | 0.0017 | 1 | | 1023 | 980 | 24 | 7 | 12 | 95.80 | 3.03 | 1.17 | 6 | G12 | |
| MLN8054 | PE/CA-PJ15 | 0.0017 | 2 | | 1869 | 1780 | 34 | 0 | 55 | 95.24 | 1.82 | 2.94 | 6 | G12 | |
| MLN8054 | PE/CA-PJ15 | 0.0017 | 3 | | 3037 | 2889 | 36 | 0 | 112 | 95.13 | 1.19 | 3.69 | 6 | G12 | |
| Tozasertib | PE/CA-PJ15 | 1.23 | 1 | | 734 | 675 | 18 | 5 | 36 | 91.96 | 3.13 | 4.90 | 6 | G13 | |
| Tozasertib | PE/CA-PJ15 | 1.23 | 2 | | 896 | 834 | 29 | 9 | 24 | 93.08 | 4.24 | 2.68 | 6 | G13 | |
| Tozasertib | PE/CA-PJ15 | 1.23 | 3 | | 855 | 796 | 56 | 1 | 2 | 93.10 | 6.67 | 0.23 | 6 | G13 | |
| PE/CA-PJ15 | 1 | | 1102 | 1042 | 19 | 8 | 33 | 94.56 | 2.45 | 2.99 | 6 | G14 | N | ||
| PE/CA-PJ15 | 2 | | 1968 | 1889 | 32 | 0 | 47 | 95.99 | 1.63 | 2.39 | 6 | G14 | N | ||
| PE/CA-PJ15 | 3 | | 3077 | 2904 | 59 | 0 | 114 | 94.38 | 1.92 | 3.70 | 6 | G14 | N | ||
| Tozasertib | PE/CA-PJ15 | 1.23 | 1 | | 670 | 618 | 22 | 4 | 26 | 92.24 | 3.88 | 3.88 | 6 | G15 | |
| Tozasertib | PE/CA-PJ15 | 1.23 | 2 | | 880 | 830 | 17 | 12 | 21 | 94.32 | 3.30 | 2.39 | 6 | G15 | |
| Tozasertib | PE/CA-PJ15 | 1.23 | 3 | | 711 | 656 | 34 | 12 | 9 | 92.26 | 6.47 | 1.27 | 6 | G15 | |
| GSK1070916 | PE/CA-PJ15 | 1.23 | 1 | | 687 | 644 | 8 | 4 | 31 | 93.74 | 1.75 | 4.51 | 6 | G16 | |
| GSK1070916 | PE/CA-PJ15 | 1.23 | 2 | | 1062 | 989 | 44 | 10 | 19 | 93.13 | 5.08 | 1.79 | 6 | G16 | |
| GSK1070916 | PE/CA-PJ15 | 1.23 | 3 | | 847 | 776 | 55 | 0 | 16 | 91.62 | 6.49 | 1.89 | 6 | G16 | |
| Tozasertib | PE/CA-PJ15 | 0.0017 | 1 | | 953 | 896 | 19 | 3 | 35 | 94.02 | 2.31 | 3.67 | 6 | G17 |